Cappelletti, Christy http://orcid.org/0000-0002-7203-7721
Maes, Andrea
Rossman, Kimberly
Gillen, Michael
LaForce, Craig
Kerwin, Edward M.
Reisner, Colin
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 12 April 2021
First Online: 4 June 2021
Declarations
:
: These two studies were solely funded by AstraZeneca.
: AstraZeneca funded the study and had a role in study design, data collection, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data and had final responsibility to submit for publication.
: AM, CC, CR, KR and MG are employees of, and own stock in, AstraZeneca. CLF has received payments from 4D Pharma PLC, Amphastar, Boehringer Ingelheim, Bond Avillion 2 Development LP, Bosch Healthcare Solutions GmbH, Cipla Ltd, GlaxoSmithKline, Knopp Biosciences LLC, Novartis Research and Development, Romark, Sanofi US Services Inc, Teva Pharmaceuticals Ltd and Vorso Corp. EK has performed consulting, served on advisory boards, and received travel reimbursement from Amphastar, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Mylan, Novartis, Sunovion and Theravance. He has conducted multicentre clinical research trials for some 40 pharmaceutical companies.
: Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca’s data sharing policy described at ExternalRef removed.
: This study was performed in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with International Conference for Harmonisation (ICH), Good Clinical Practice (GCP), and applicable regulatory requirements.
: The Investigator was responsible for obtaining written informed consent (and assent, where applicable) from potential subjects before any study-specific screening and entry into the study. After the subject signed the ICF (and/or assent form, where applicable), the original was retained by the Investigator; the subject retained a copy.
: Not applicable.
: CC: Conceptualisation; data curation; investigation; methodology; supervision; validation; visualisation; roles/writing—original draft; writing—review and editing. AM: Conceptualisation; investigation; methodology; supervision; validation; visualisation; roles/writing—original draft; writing—review and editing. KR: Conceptualisation; investigation; methodology; project administration; resources; supervision; validation; roles/writing—original draft; writing—review and editing. MG: Conceptualisation; investigation; methodology; supervision; validation; visualisation; writing—review and editing. CLF: Data curation; methodology; writing—review and editing. EK: Data curation; investigation; methodology; writing—review and editing. CR: Conceptualisation; funding acquisition; methodology; supervision; validation; writing—review and editing.